Insider · CIK 0001726148
Karen L. Alvingham
Files at AMG (AFFILIATED MANAGERS GROUP, INC.). First filing -, latest -.
Karen L. Alvingham files SEC Form 4 as director at AMG (AFFILIATED MANAGERS GROUP, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Karen L. Alvingham has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Common Stock | +867 | $0.00 | $0 | 13,110 | Mar 9, 2026 |
| Mar 5, 2026 | AMG AFFILIATED MANAGERS GROUP, INC. | FTax withholding Common Stock | -67 | $299.18 | $20k | 13,043 | Mar 9, 2026 |
| Mar 5, 2026 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Stock Unitsderivative | -867 | $0.00 | $0 | 3,709 | Mar 9, 2026 |
| Mar 5, 2026 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Stock Unitsderivative | +171 | $0.00 | $0 | 171 | Mar 9, 2026 |
| Mar 5, 2026 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Deferred Stock Unitsderivative | +98 | $0.00 | $0 | 98 | Mar 9, 2026 |
| Nov 7, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Common Stock | +560 | $69.63 | $39k | 12,425 | Nov 12, 2025 |
| Nov 7, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | FTax withholding Common Stock | -182 | $259.26 | $47k | 12,243 | Nov 12, 2025 |
| Nov 7, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Director Stock Option (Right to Buy)derivative | -560 | $0.00 | $0 | 0 | Nov 12, 2025 |
| Aug 15, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Common Stock | +1,092 | $0.00 | $0 | 11,949 | Aug 18, 2025 |
| Aug 15, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | FTax withholding Common Stock | -84 | $218.70 | $18k | 11,865 | Aug 18, 2025 |
| Aug 14, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Deferred Stock Unitsderivative | +262 | $0.00 | $0 | 262 | Aug 18, 2025 |
| Aug 15, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Stock Unitsderivative | -1,092 | $0.00 | $0 | 4,313 | Aug 18, 2025 |
| Jul 31, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Restricted Stock Unitsderivative | +477 | $0.00 | $0 | 477 | Aug 4, 2025 |
| Mar 5, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Common Stock | +1,178 | $0.00 | $0 | 10,947 | Mar 7, 2025 |
| Mar 5, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | FTax withholding Common Stock | -90 | $165.72 | $15k | 10,857 | Mar 7, 2025 |
| Mar 5, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | MOption exercise Stock Unitsderivative | -1,178 | $0.00 | $0 | 4,928 | Mar 7, 2025 |
| Feb 6, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Restricted Stock Unitsderivative | +548 | $0.00 | $0 | 548 | Feb 10, 2025 |
| Feb 6, 2025 | AMG AFFILIATED MANAGERS GROUP, INC. | AGrant or award Deferred Stock Unitsderivative | +320 | $0.00 | $0 | 320 | Feb 10, 2025 |
Questions about Karen L. Alvingham
Answered from the filings on this page, as of the latest one.
Is Karen L. Alvingham buying or selling?
Karen L. Alvingham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Karen L. Alvingham's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karen L. Alvingham has 0.
Where does Karen L. Alvingham file Form 4?
Karen L. Alvingham has filed Form 4 at AMG (AFFILIATED MANAGERS GROUP, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.